var path='https://www.tickertech.net'; function heading(heading) { document.write('
'+heading+' |
'+ ''+ ' |
'); } function hiLite(imgDocID,imgObjName) { document.images[imgDocID].src = eval(imgObjName + ".src"); } function showStatus(toshow) { window.status = toshow; } function checkChoose() { if (document.choose.ticker.value == "") { alert("Please enter symbols before clicking the go button"); return false; } else return true; } function popJT(url,name){ var xwid = screen.width; xwid = xwid - 10; javaticker = window.open(url,name,'width='+xwid+',height=100,resizable=yes,scrollbars=no,toolbar=no,location=no,directories=no,status=yes,menubar=no'); javaticker.opener.name="opener"; //javaticker.moveTo(0,30); } var allow = 0; var ref = ""+location; if ((ref.indexOf("cryptocurrencieschannel.com") > 0) || (ref.indexOf("cefchannel.com") > 0) || (ref.indexOf("bdcinvestor.com") > 0) || (ref.indexOf("tickertech.com") > 0) || (ref.indexOf("xxxx:") > 0) || (ref.indexOf("javascript:") > 0) || (ref.indexOf("filseclab.com") > 0) || (ref.indexOf("msnscache.com") > 0) || (ref.indexOf("toolbar.google.com") > 0) || (ref.indexOf("etfchannel.com") > 0) || (ref.indexOf("marketnewsvideo.com") > 0) || (ref.indexOf("news.google.com") > 0) || (ref.indexOf("dividendchannel.com") > 0) || (ref.indexOf("www.google.com") > 0) || (ref.indexOf("energystockchannel.com") > 0) || (ref.indexOf("metalschannel.com") > 0) || (ref.indexOf("portfoliochannel.com") > 0) || (ref.indexOf("canadastockchannel.com") > 0) || (ref.indexOf("theonlineinvestor.com") > 0) || (ref.indexOf("investhelp.com") > 0) || (ref.indexOf("preferredstockchannel.com") > 0) || (ref.indexOf("stockoptionschannel.com") > 0) || (ref.indexOf("holdingschannel.com") > 0) || (ref.indexOf("tickertech.net") > 0) || (ref.indexOf("historicalstockprice.com") > 0) || (ref.indexOf("splithistory.com") > 0) || (ref.indexOf("stocksplithistory.com") > 0) || (ref.indexOf("google.c") > 0) || (ref.indexOf("208.71.46.190") > 0) || (ref.indexOf("search.yahoo") > 0) || (ref.indexOf("sharesoutstandinghistory.com") > 0) || (ref.indexOf("marketcaphistory.com") > 0) || (ref.indexOf("ytdreturn.com") > 0) || (ref.indexOf("averageannualreturn.com") > 0) || (ref.indexOf("redinews.com") > 0) || (ref.indexOf("technicalanalysischannel.com") > 0) || (ref.indexOf("stockdma.com") > 0) || (ref.indexOf("stockrsi.com") > 0) || (ref.indexOf("stockmacd.com") > 0) || (ref.indexOf("topdividends.com") > 0) || (ref.indexOf("monthlydividendpayingstocks.com") > 0) || (ref.indexOf("nextearningsdate.com") > 0) || (ref.indexOf("pastearnings.com") > 0) || (ref.indexOf("historicalperatio.com") > 0) || (ref.indexOf("historicalearnings.com") > 0) || (ref.indexOf("webcache.googleusercontent.com") > 0)) { allow = 1; } function ShowTTIPage() { if (allow) { document.write('\n'); } if (allow) { document.write('
\n'); } if (allow) { document.write('4/25 - 4:05 PM \; \; | \n'); } if (allow) { document.write('Aligos Therapeutics Presents Positive Clinical Data at ESCMID 2024 from the ALG-097558 Phase 1 Study | \n'); } if (allow) { document.write('
4/25 - 8:04 AM \; \; | \n'); } if (allow) { document.write('Aligos Therapeutics Mourns the Passing of MASH Industry Leader Stephen A. Harrison, MD | \n'); } if (allow) { document.write('
4/9 - 8:00 AM \; \; | \n'); } if (allow) { document.write('Aligos Therapeutics to Participate in the Piper Sandler Spring Biopharma Symposium 2024 | \n'); } if (allow) { document.write('
4/3 - 8:00 AM \; \; | \n'); } if (allow) { document.write('Aligos Therapeutics Announces First Subjects Dosed in the Phase 2a HERALD Study of ALG-055009 in MASH Subjects | \n'); } if (allow) { document.write('
3/27 - 8:00 AM \; \; | \n'); } if (allow) { document.write('Aligos Therapeutics Presents Positive Clinical Data at APASL 2024 from ALG-055009 and ALG-000184 Phase 1 Studies | \n'); } if (allow) { document.write('
3/18 - 8:00 AM \; \; | \n'); } if (allow) { document.write('Aligos Therapeutics Announces the Initiation of the Phase 2a HERALD Study of ALG-055009 in MASH Subjects | \n'); } if (allow) { document.write('
3/12 - 4:05 PM \; \; | \n'); } if (allow) { document.write('Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results | \n'); } if (allow) { document.write('
3/5 - 4:05 PM \; \; | \n'); } if (allow) { document.write('Aligos Therapeutics to Announce 4th Quarter 2023 Financial Results on March 12, 2024 | \n'); } if (allow) { document.write('
2/26 - 8:00 AM \; \; | \n'); } if (allow) { document.write('Aligos Therapeutics To Participate in the Leerink Partners Global Biopharma Conference 2024 | \n'); } if (allow) { document.write('
2/20 - 8:02 AM \; \; | \n'); } if (allow) { document.write('Aligos Therapeutics to Host KOL Event to Discuss Phase 2a HERALD Study of ALG-055009 in MASH on March 7, 2024 | \n'); } if (allow) { document.write('
2/13 - 8:04 AM \; \; | \n'); } if (allow) { document.write('Aligos Therapeutics Strengthens Finance Leadership Team with Two New Appointments | \n'); } if (allow) { document.write('
\n'); } if (allow) { document.write(' |